Promotie onderzoek

KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn38resultaten gevonden
Farmacokinetiek en -dynamiek

Dose individualization of Beta-lactam and Ciprofloxacin in ICU patients: To TDM or not to TDM

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Alan Abdulla
  • Promoters Birgit Koch
  • Co-Promoters Rik Endeman Anouk Muller
  • Jaar 2018 - 2022
  • A prospective observational PK/PD to study the target attainment for β-lactam antibiotics in critical ill patients and its associated risk factors.
  • A multi-centre, randomised controlled trial to assess the efficacy and cost-effectiveness of model-based TDM of beta-lactam and fluoroquinolone antibiotics.
Farmacokinetiek en -dynamiek

PK/PD of betalactamantibiotics

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Eveline Roelofsen
  • Promoters Birgit Koch
  • Co-Promoters Brenda de Winter Anouk Muller
  • Jaar 2019 - 2023
  1. Optimasation of the flucloxacillin absorptiontest.
  2. PK modeeling of cefotaxim in critically ill patients.
  3. PK modeling of flucloxacillin in mice.
Medicatieveiligheid

Clinical rules in de huiartsenpraktijk

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Fauzia Chitanie
  • Promoters Hugo van der Kuy
  • Co-Promoters Floor van Rosse Kees van Boven
  • Jaar 2019 - 2024

Meerwaarde van clinical rules in de eerste lijn.

Medicatieveiligheid

Alert Fatigue

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Bob van der Loo
  • Promoters Hugo van der Kuy
  • Co-Promoters Heleen van der Sijs
  • Jaar 2020 - 2024

Optimalisatie van het clinical decision support system.

Farmacokinetiek en -dynamiek

Improving the pharmaceutical care for (liver) transplant recipients

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Midas B. Mulder
  • Promoters Prof. Dr. Herold Metselaar
  • Co-Promoters Dr. B.C.M. de Winter Dr. S. Darwish Murad
  • Jaar 2019 - 2023

Part 1: Optimizing ribavirin therapy in transplant recipients with a chronic hepatitis E virus infection by devoloping a NONMEM model for ribavirin. Part 2: Improving immunosuppressive therapy in liver transplant recipients by performing 2 RCT's in which different immunosuppresive strategies will be compared to modify the tacrolimus related toxicity in this population. Part 3: Evaluate the contribution of an outpatient medication service for liver transplant recipients.

Therapietrouw

Resistant HYpertension: MEasure To ReaCh Targets (RHYME-RCT)

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Laura Peeters
  • Promoters Prof. dr. Teun van Gelder
  • Co-Promoters Dr. B.C.P. Koch Dr. J. Versmissen
  • Jaar 2018 - 2022

RHYME-RCT is a multi-center randomized controlled trial to identify and improve non-adherence in patients with resistant hypertension and are included from 10 peripheral and 2 academic hospitals. Non-adherence is measured by means of a validated dried blood spot method. This method includes 17 antihypertensive drugs from different drug classes.

Farmaco-economie

Advances in chemo-efficiency

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Ruben Malmberg
  • Promoters Stefan Sleijfer Prof. Dr. Birgit Koch
  • Co-Promoters Roelof van Leeuwen
  • Jaar 2020 - 2024
  1. The safety of short hydration during cisplatin chemoradiation in head and neck cancer patients: a randmized controlled trial.
  2. The feasibility of 6 monthly gosereline injections in prostate cancer patients. 
  3. Nivolumab administration through an elastomeric pump versus iv bag administration: a patient preference study.
Pagina 2 van 6